重症监护病房中的药物水平 - 对或错。
Drug Levels in ICU - T or F.
作者信息
Hegde Ashit
机构信息
Medicine and Intensive Care, PD Hinduja Hospital, Mumbai, Maharashtra, India.
出版信息
Indian J Crit Care Med. 2022 Jun;26(6):663. doi: 10.5005/jp-journals-10071-24261.
Abstract
Hegde A. Drug Levels in ICU - T or F. Indian J Crit Care Med 2022;26(6):663.
摘要
赫格德 A. 重症监护病房中的药物水平——对还是错。《印度重症监护医学杂志》2022年；26(6):663。
相似文献
1
Drug Levels in ICU - T or F.重症监护病房中的药物水平 - 对或错。
Indian J Crit Care Med. 2022 Jun;26(6):663. doi: 10.5005/jp-journals-10071-24261.
2
Estimation of Free Phenytoin Concentration in Critically Ill Patients with Hypoalbuminemia: Direct-measurement vs Traditional Equations.低白蛋白血症重症患者游离苯妥英浓度的估算：直接测量与传统公式比较
Indian J Crit Care Med. 2022 Jun;26(6):682-687. doi: 10.5005/jp-journals-10071-24235.
3
Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia.低白蛋白血症神经重症监护患者中游离苯妥英血清浓度测量值与计算值之间的相关性
Clin Pharmacol. 2018 Dec 13;10:183-190. doi: 10.2147/CPAA.S186322. eCollection 2018.
4
Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients.危重症患者血清中游离苯妥英和总苯妥英浓度的相关性
Ann Pharmacother. 2016 Apr;50(4):276-81. doi: 10.1177/1060028015627468. Epub 2016 Jan 18.
5
A Comprehensive Review on the Predictive Performance of the Sheiner-Tozer and Derivative Equations for the Correction of Phenytoin Concentrations.关于用于校正苯妥英浓度的谢纳 - 托泽方程及衍生方程预测性能的综合综述
Ann Pharmacother. 2016 Apr;50(4):311-25. doi: 10.1177/1060028016628166. Epub 2016 Jan 29.
6
Estimating phenytoin concentrations by the Sheiner-Tozer method in adults with pronounced hypoalbuminemia.采用谢纳-托泽方法估算严重低白蛋白血症成人患者的苯妥英浓度。
Ann Pharmacother. 1995 Jul-Aug;29(7-8):667-70. doi: 10.1177/106002809502907-802.
7
Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.总苯妥英浓度不能准确预测重症患儿的游离苯妥英浓度。
Pediatr Crit Care Med. 2006 Sep;7(5):434-9; quiz 440. doi: 10.1097/01.PCC.0000235252.43921.DE.
8
Free phenytoin assessment in patients: measured versus calculated blood serum levels.患者游离苯妥英评估：实测血清水平与计算血清水平对比
Int J Clin Pharm. 2016 Apr;38(2):303-9. doi: 10.1007/s11096-015-0241-x. Epub 2016 Jan 8.
9
Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient.预测重症神经外科患者的游离苯妥英浓度。
Ann Pharmacother. 1996 Mar;30(3):219-23. doi: 10.1177/106002809603000301.
10
Therapeutic Drug Monitoring of Isavuconazole-But What about the Critically Ill?艾沙康唑的治疗药物监测——那重症患者呢？
Indian J Crit Care Med. 2023 Jun;27(6):454-455. doi: 10.5005/jp-journals-10071-24450.
本文引用的文献
1
Fatal MDR in ICU - How was it Dealt with?重症监护病房中的致命多重耐药菌感染——是如何应对的？
Indian J Crit Care Med. 2019 Sep;23(9):411-413. doi: 10.5005/jp-journals-10071-23235.
2
Early phase clinical trials to identify optimal dosing and safety.开展早期临床试验以确定最佳剂量和安全性。
Mol Oncol. 2015 May;9(5):997-1007. doi: 10.1016/j.molonc.2014.07.025. Epub 2014 Aug 14.
3
Introduction to drug pharmacokinetics in the critically ill patient.危重症患者的药物药代动力学简介。
Chest. 2012 May;141(5):1327-1336. doi: 10.1378/chest.11-1396.
4
Overview of therapeutic drug monitoring.治疗药物监测概述。
Korean J Intern Med. 2009 Mar;24(1):1-10. doi: 10.3904/kjim.2009.24.1.1.
5
The clinical value of free phenytoin levels.
Ann Neurol. 1985 Jul;18(1):90-3. doi: 10.1002/ana.410180116.
Zotero 插件